Handelsavisen
prelaunch
Companies Healthcare 065510.KQ
06
065510.KQ KOSDAQ Advanced Medical Equipment & Technology

065510.Kq

$7 110,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
3,18 %
Op margin
-4,0 %
ROE
-4,7 %
Net margin
-4,2 %
Debt / equity
0,73
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

The company designs, develops, and sells medical equipment and technology, primarily serving the healthcare sector.

Business. The company designs, develops, and sells medical equipment and technology, primarily serving the healthcare sector.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
ActivityHealthcare Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-4,7 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 065510.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 065510.KQ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    The company designs, develops, and sells medical equipment and technology, primarily serving the healthcare sector.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryAdvanced Medical Equipment & Technology
    ActivityHealthcare Equipment
    AI synthesis
    GENERATED

    The company's capital structure is characterized by a debt-to-equity ratio of 0.73, indicating a moderate reliance on debt financing. However, its liquidity position is weak, with only 250 KRW in cash and equivalents and a negative free cash flow of -7,265,051,230 KRW. This is exacerbated by a negative net income of -4,973,820,460 KRW and an operating loss of -4,729,657,540 KRW, which together suggest a deteriorating financial position.

    Profitability metrics are notably poor, with a return on equity of -4.71% and a return on assets of -2.21%. These figures fall significantly below the industry median for profitability, indicating that the company is underperforming its peers in terms of generating returns from its equity and asset base.

    The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification increases exposure to regional economic or regulatory risks, though the exact geographic breakdown is not available in the current dataset.

    The company's growth trajectory is uncertain, with no clear indication of revenue growth in the current fiscal year. The operating cash flow of 12,661,205,390 KRW is insufficient to cover capital expenditures of -7,618,972,960 KRW, suggesting that the company is investing heavily in its operations but is not generating enough cash to sustain these investments without external financing.

    Risk factors include a medium liquidity risk, as the company has negative net cash after subtracting total debt. The dilution risk is currently low, but the company's negative free cash flow and operating loss may necessitate future equity or debt financing, which could lead to share dilution. No specific dilution sources are identified in the available documents.

    Recent events include a reported operating loss and a negative net income, as disclosed in the latest financial statements. No recent filings or transcripts have been provided that detail specific strategic or operational changes, but the financial performance suggests a challenging operating environment.

    Key takeaways
    • The company is experiencing a significant operating loss and negative net income, indicating poor financial performance.
    • The company's liquidity position is weak, with minimal cash and a negative free cash flow.
    • The debt-to-equity ratio of 0.73 suggests a moderate reliance on debt, but the company's profitability is insufficient to support this leverage.
    • The company's capital expenditures are not being funded by its operating cash flow, indicating a need for external financing.
    • The company's financial performance is below industry medians for profitability and return metrics.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $7 110,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $105.52B
    Net cash
    -$77.17B
    Current ratio
    1.1
    Debt / equity
    0.7
    ROA
    -2.2%
    ROE
    -4.7%
    Cash conversion
    -255.0%
    CapEx / revenue
    -6.5%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-4,0 %Above median
    Net Margin-4,2 %Above median
    ROE-4,7 %Below median
    Capex / Rev-6,5 %Below median
    D/E0,73Bottom quartile
    Cash Conv-2,55Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • 065510.KQ Market data — financials · 2026-05-26
    • Huvitz Co Ltd Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    065510.KQCanonical
    KOSDAQ · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage